Startups, philanthropy, billionaires, academia, neuromodulation, psychedelics, AI and new therapies in bipolar, autism, and Parkinson’s with Rob Malenka

Matias interviews Rob Malenka, Chief Scientific Officer of Bayshore, the family office of Google co-founder Sergey Brin.  Bayshore has played a major role in advancing treatments for Parkinson's, bipolar, and autism.

In this episode, we discuss:

• Why progress in psychiatry is slow because the brain is the most complex organ and many disorders are highly heterogeneous
• The bottlenecks including weak replicability in research, academic politics, perverse incentives, and pharma’s avoidance of neuropsychiatry
• How breakthroughs require early detection, rigorous science, and bridging academia with biotech through venture philanthropy
• How success depends on mission-driven, ethical people who align science, capital, and patient impact.
• The opportunities in neuromodulation, data-driven precision medicine, and combination therapies.

Credits:

Created by Greg Kubin and Matias Serebrinsky
Host: Matias Serebrinsky
Produced by Caitlin Ner & Nico V. Rey

Find us at businesstrip.fm and psymed.ventures
Follow us on Instagram and Twitter!
Theme music by Dorian Love
Additional Music: Distant Daze by Zack Frank